Clinical trial
Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea…
NCT00250744 · New Mexico Cancer Research Alliance, Other · Completed
Key facts
| NCT number | NCT00250744 |
|---|---|
| Title | Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting |
| Official title | Comparison of Aprepitant vs. Gabapentin in the Prevention of Delayed Nausea and Vomiting |
| Lead sponsor | New Mexico Cancer Research Alliance, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | Aprepitant vs. Gabapentin |
| Enrollment | 200 |
| Start date | Dec 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Nov 8, 2005 |
| Last update posted | Sep 27, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: